147 related articles for article (PubMed ID: 29992318)
1. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
Lee YY; Mok MT; Kang W; Yang W; Tang W; Wu F; Xu L; Yan M; Yu Z; Lee SD; Tong JHM; Cheung YS; Lai PBS; Yu DY; Wang Q; Wong GLH; Chan AM; Yip KY; To KF; Cheng ASL
Nucleic Acids Res; 2018 Sep; 46(17):8832-8847. PubMed ID: 29992318
[TBL] [Abstract][Full Text] [Related]
2. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
[TBL] [Abstract][Full Text] [Related]
3. Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.
Xie CR; Li Z; Sun HG; Wang FQ; Sun Y; Zhao WX; Zhang S; Zhao WX; Wang XM; Yin ZY
Oncotarget; 2015 Dec; 6(38):40940-52. PubMed ID: 26517514
[TBL] [Abstract][Full Text] [Related]
4. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma.
Zhang L; Li HT; Shereda R; Lu Q; Weisenberger DJ; O'Connell C; Machida K; An W; Lenz HJ; El-Khoueiry A; Jones PA; Liu M; Liang G
Cancer Lett; 2022 Nov; 548():215899. PubMed ID: 36087682
[TBL] [Abstract][Full Text] [Related]
5. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
Li XJ; Zhou F; Li YJ; Xue XY; Qu JR; Fan GF; Liu J; Sun R; Wu JZ; Zheng Q; Liu RP
Acta Pharmacol Sin; 2023 Dec; 44(12):2479-2491. PubMed ID: 37580495
[TBL] [Abstract][Full Text] [Related]
6. EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.
Huang Y; Durall RT; Luong NM; Hertzler HJ; Huang J; Gokhale PC; Leeper BA; Persky NS; Root DE; Anekal PV; Montero Llopis PDLM; David CN; Kutok JL; Raimondi A; Saluja K; Luo J; Zahnow CA; Adane B; Stegmaier K; Hawkins CE; Ponne C; Le Q; Shapiro GI; Lemieux ME; Eagen KP; French CA
Cancer Res; 2023 Dec; 83(23):3956-3973. PubMed ID: 37747726
[TBL] [Abstract][Full Text] [Related]
7. MELK aggravates lung adenocarcinoma by regulating EZH2 ubiquitination and H3K27me3 histone methylation of LATS2.
Yu H; Xu X; Zhu L; Chen S; He J
J Cell Mol Med; 2024 Apr; 28(8):e18216. PubMed ID: 38652219
[TBL] [Abstract][Full Text] [Related]
8. Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor.
Zhang T; Gong Y; Meng H; Li C; Xue L
Clin Epigenetics; 2020 May; 12(1):72. PubMed ID: 32448308
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming.
Tang Y; Zhao L; Yu X; Zhang J; Qian L; Jin J; Lu R; Zhou Y
Stem Cell Res; 2021 May; 53():102365. PubMed ID: 34087994
[TBL] [Abstract][Full Text] [Related]
10. The SOX4/EZH2/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury.
Yan X; Xia Y; Li B; Ye Z; Li L; Yuan T; Song B; Yu W; Rao T; Ning J; Lin F; Mei S; Mao Z; Zhou X; Li W; Cheng F
J Transl Med; 2024 Jan; 22(1):9. PubMed ID: 38169402
[TBL] [Abstract][Full Text] [Related]
11. Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
He X; Li M; Yu H; Liu G; Wang N; Yin C; Tu Q; Narla G; Tao Y; Cheng S; Yin H
PLoS Biol; 2020 Dec; 18(12):e3000803. PubMed ID: 33275593
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein.
Tripathi BK; Anderman MF; Bhargava D; Boccuzzi L; Qian X; Wang D; Durkin ME; Papageorge AG; de Miguel FJ; Politi K; Walters KJ; Doroshow JH; Lowy DR
Nat Commun; 2021 Dec; 12(1):6941. PubMed ID: 34862367
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier dysfunction mediated by the EZH2-Claudin-5 axis drives stress-induced TNF-α infiltration and depression-like behaviors.
Sun ZW; Wang X; Zhao Y; Sun ZX; Wu YH; Hu H; Zhang L; Wang SD; Li F; Wei AJ; Feng H; Xie F; Qian LJ
Brain Behav Immun; 2024 Jan; 115():143-156. PubMed ID: 37848095
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer.
Ghate NB; Kim S; Shin Y; Kim J; Doche M; Valena S; Situ A; Kim S; Rhie SK; Lenz HJ; Ulmer TS; Mumenthaler SM; An W
Nat Commun; 2023 Apr; 14(1):2140. PubMed ID: 37069142
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway.
Chen S; Wang Q; Yu H; Capitano ML; Vemula S; Nabinger SC; Gao R; Yao C; Kobayashi M; Geng Z; Fahey A; Henley D; Liu SZ; Barajas S; Cai W; Wolf ER; Ramdas B; Cai Z; Gao H; Luo N; Sun Y; Wong TN; Link DC; Liu Y; Boswell HS; Mayo LD; Huang G; Kapur R; Yoder MC; Broxmeyer HE; Gao Z; Liu Y
Nat Commun; 2019 Dec; 10(1):5649. PubMed ID: 31827082
[TBL] [Abstract][Full Text] [Related]
16. Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.
Zhang X; Wang Y; Yuan J; Li N; Pei S; Xu J; Luo X; Mao C; Liu J; Yu T; Gan S; Zheng Q; Liang Y; Guo W; Qiu J; Constantin G; Jin J; Qin J; Xiao Y
J Exp Med; 2018 May; 215(5):1365-1382. PubMed ID: 29626115
[TBL] [Abstract][Full Text] [Related]
17. Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development.
Wen Z; He K; Zhan M; Li Y; Liu F; He X; Wei Y; Zhao W; Zhang Y; Xue Y; Xia Y; Wang F; Xia Z; Xin Y; Wu Y; Duan X; Xiao J; Shen F; Feng Y; Xiang G; Lu L
Front Oncol; 2022; 12():904633. PubMed ID: 36578923
[TBL] [Abstract][Full Text] [Related]
18. EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.
Huang Y; Durall RT; Luong NM; Hertzler HJ; Huang J; Gokhale PC; Leeper BA; Persky NS; Root DE; Anekal PV; Montero Llopis PDLM; David CN; Kutok JL; Raimondi A; Saluja K; Luo J; Zahnow CA; Adane B; Stegmaier K; Hawkins CE; Ponne C; Le Q; Shapiro GI; Lemieux ME; Eagen KP; French CA
bioRxiv; 2023 Aug; ():. PubMed ID: 37645799
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma.
Chan FF; Yuen VW; Shen J; Chin DW; Law CT; Wong BP; Chan CY; Cheu JW; Ng IO; Wong CC; Wong CM
Hepatology; 2023 Dec; ():. PubMed ID: 38051950
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.
Roy R; Kandimalla R; Sonohara F; Koike M; Kodera Y; Takahashi N; Yamada Y; Goel A
Int J Cancer; 2019 Mar; 144(5):1160-1169. PubMed ID: 30006931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
